BillionToOne, Inc. Class A Common Stock (BLLN)
BillionToOne, Inc. Class A Common Stock (BLLN) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.
As of Oct 23, 2026: market cap $4.8B; returns 1 day +2.0%, 1 week +9.8%.
BillionToOne, Inc. is a molecular diagnostics company focused on developing and commercializing powerful and accurate tests using its proprietary Quantitative Counting Templates (QCT) molecular counting platform. This technology enables the detection and quantification of DNA molecules at the single-molecule level from cell-free DNA (cfDNA) in blood samples.
Groups BLLN belongs to
- Healthcare
- Biotechnology
- Recent IPOs
- Health Diagnostics and Imaging
- Life Sciences
- Oncology
- Precision Medicine
- Women's Health
- Personalized Medicine
- Life Sciences Tools & Services
- Healthcare Technology
- Clinical Stage
- Commercial Stage
BLLN financial model: income statement, cash flow and balance sheet